Brief: Pharmena Gets Mexican Patent For 1-MNA In Cardiac Cases
March 31 (Reuters) - Pharmena SA PHR.WA :
* SAYS GETS MEXICAN PATENT FOR IMPLEMENTATION OF 1-MNA FOR
CARDIAC
DISEASES WITH HIGHER LEVEL OF CRP
Source text for Eikon: ID:nEMhYzLha
Further company coverage: PHR.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharmena SA
See all newsBrief: Pharmena Makes Cession Of Rights And Obligations From Unit Menavitin
Brief: Pharmena Signs Two Distribution Deals For US, Canada And Mexico Markets
Brief: Pharmena 9-Month Net Loss Narrows To 0.7 Mln Zlotys
Brief: Pharmena Plans To Separate Dermocosmetic Business
Brief: Pharmena H1 Net Loss Narrows To 0.6 Mln Zlotys